Trademark: 79221633
Status Date
Friday, May 8, 2020
Filing Date
Thursday, January 26, 2017
Published for Opposition
Tuesday, April 3, 2018
Abandoned Date
Friday, May 8, 2020
5 Sanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses such as varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, and adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infectious diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses such as varicella and infectious mononucleosis; antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, and adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; drugs for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based drugs pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infectious diseases
May 30, 2021
Final Decision Transaction Processed By Ib
May 10, 2021
Final Disposition Notice Sent To Ib
May 8, 2021
Final Disposition Notice Created, To Be Sent To Ib
May 8, 2020
Abandonment Notice E-Mailed - Inter Partes Decision
May 8, 2020
Abandonment - After Inter Partes Decision
May 8, 2020
Opposition Terminated No. 999999
May 8, 2020
Opposition Dismissed No. 999999
Apr 21, 2020
Limitation From The Ib Examined And Entered
Feb 7, 2020
Limitation Of Goods Received From Ib
May 10, 2019
Notification Of Possible Opposition - Processed By Ib
Apr 24, 2019
Notification Of Possible Opposition Sent To Ib
Apr 24, 2019
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 8, 2018
Refusal Processed By Ib
May 17, 2018
Opposition Instituted No. 999999
May 16, 2018
Opposition Notice (Ib Refusal) Sent To Ib
May 16, 2018
Opposition Notice (Ib Refusal) Created
May 4, 2018
Change Of Name/Address Rec'd From Ib
May 3, 2018
Extension Of Time To Oppose Received
Apr 3, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 3, 2018
Published For Opposition
Mar 14, 2018
Notification Of Notice Of Publication E-Mailed
Feb 28, 2018
Approved For Pub - Principal Register
Feb 7, 2018
Teas/Email Correspondence Entered
Feb 6, 2018
Correspondence Received In Law Office
Feb 6, 2018
Teas Request For Reconsideration Received
Feb 1, 2018
Notification Of Final Refusal Emailed
Feb 1, 2018
Final Refusal E-Mailed
Feb 1, 2018
Final Refusal Written
Jan 19, 2018
Refusal Processed By Ib
Jan 11, 2018
Teas/Email Correspondence Entered
Jan 10, 2018
Correspondence Received In Law Office
Jan 10, 2018
Teas Response To Office Action Received
Dec 30, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Dec 30, 2017
Refusal Processed By Mpu
Dec 19, 2017
Teas Change Of Correspondence Received
Dec 15, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Dec 14, 2017
Non-Final Action Written
Dec 12, 2017
Application Filing Receipt Mailed
Dec 7, 2017
Assigned To Examiner
Dec 7, 2017
New Application Office Supplied Data Entered In Tram
Nov 23, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
